These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. Swischuk JL; Fox PF; Young K; Hussain S; Smouse B; Castañeda F; Brady TM J Vasc Interv Radiol; 2001 Apr; 12(4):423-30. PubMed ID: 11287527 [TBL] [Abstract][Full Text] [Related]
3. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis. Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257 [TBL] [Abstract][Full Text] [Related]
4. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital. Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822 [TBL] [Abstract][Full Text] [Related]
5. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions. McNamara TO; Dong P; Chen J; Quinn B; Gomes A; Goodwin S; Aban K Tech Vasc Interv Radiol; 2001 Jun; 4(2):92-8. PubMed ID: 11981794 [TBL] [Abstract][Full Text] [Related]
6. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. Drescher P; Crain MR; Rilling WS J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692 [TBL] [Abstract][Full Text] [Related]
7. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. Ouriel K; Gray B; Clair DG; Olin J J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422 [TBL] [Abstract][Full Text] [Related]
8. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions. Yoon HC; Miller FJ AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686 [TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of Rt-pa thrombolysis combined with PGE1 in patients with peripheral arterial occlusions. Kröger K; Buss C; Rudofsky G Angiology; 2000 May; 51(5):377-84. PubMed ID: 10826854 [TBL] [Abstract][Full Text] [Related]
10. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684 [TBL] [Abstract][Full Text] [Related]
13. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. Castañeda F; Swischuk JL; Li R; Young K; Smouse B; Brady T J Vasc Interv Radiol; 2002 Nov; 13(11):1093-8. PubMed ID: 12427807 [TBL] [Abstract][Full Text] [Related]
14. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039 [TBL] [Abstract][Full Text] [Related]
15. Intraarterial recombinant tissue plasminogen activator thrombolysis of acute and semiacute lower limb arterial occlusion: quality assurance, complication management, and 12-month follow-up reinterventions. Kühn JP; Hoene A; Miertsch M; Traeger T; Langner S; Hosten N; Puls R AJR Am J Roentgenol; 2011 May; 196(5):1189-93. PubMed ID: 21512091 [TBL] [Abstract][Full Text] [Related]
16. Acute and long-term results after intra-arterial thrombolysis of occluded lower extremity bypass grafts using recombinant tissue plasminogen activator for acute limb-threatening ischemia. Khosla S; Jain P; Manda R; Razminia M; Guerrero M; Trivedi A; Vidyarthi V; Elbazour M; Kunjummen B; Ahmed A; Lubell D Am J Ther; 2003; 10(1):3-6. PubMed ID: 12522513 [TBL] [Abstract][Full Text] [Related]
17. Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation? Si TG; Guo Z; Hao XS Clin Radiol; 2008 Oct; 63(10):1136-41. PubMed ID: 18774361 [TBL] [Abstract][Full Text] [Related]
18. [Low-dose thrombolysis using rt-Pa in extensive peripheral vascular occlusion]. Jung EM; Lutz R; Rupp N Rofo; 2000 Dec; 172(12):1028-34. PubMed ID: 11199431 [TBL] [Abstract][Full Text] [Related]
19. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog. Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779 [TBL] [Abstract][Full Text] [Related]
20. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. Castaneda F; Li R; Young K; Swischuk JL; Smouse B; Brady T J Vasc Interv Radiol; 2002 Jun; 13(6):577-80. PubMed ID: 12050297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]